(NP (NP (NP (DT A) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (JJ antiinflammatory) (NNS effects)) (PP (IN of) (NP (NNS corticosteroids))))) (: :)) (S (NP-SBJ (DT the) (NN glucocorticoid) (NN receptor)) (VP (VBZ regulates) (NP-COOD (NP (NP (NN leukocyte) (NN adhesion)) (PP (TO to) (NP (JJ endothelial) (NNS cells)))) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP-COOD (NP (JJ endothelial-leukocyte) (NN adhesion) (NN molecule) (CD 1)) (CC and) (NP (JJ intercellular) (NN adhesion) (NN molecule) (CD 1))))))) (. .)))
(S (NP-SBJ (NNS Corticosteroids)) (VP (VBP are) (NP-PRD (DT the) (JJ preeminent) (JJ antiinflammatory) (NNS agents)) (SBAR (IN although) (S (NP-SBJ-9 (NP (DT the) (JJ molecular) (NNS mechanisms)) (SBAR (WHNP-10 (WDT that)) (S (NP-SBJ (-NONE- *T*-10)) (VP (VBP impart) (NP (PRP$ their) (NN efficacy)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN defined) (NP (-NONE- *-9)))))))) (. .))
(S (NP-SBJ-11 (DT The) (NN endothelium)) (VP (VBZ plays) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NN inflammation))) (PP (IN by) (S (NP-SBJ-12 (-NONE- *-11)) (VP (VBG directing) (NP (VBG circulating) (NNS leukocytes)) (PP (IN into) (NP (JJ extravascular) (NNS tissues))) (PP (IN by) (S (NP-SBJ (-NONE- *-12)) (VP (VBG expressing) (NP (NP (NP (JJ adhesive) (NNS molecules)) (PP (IN for) (NP (NNS leukocytes)))) (PRN (-LRB- -LCB-) (PP (FW e.g.) (, ,) (NP-COOD (NP (NP (JJ endothelial-leukocyte) (NN adhesion) (NN molecule) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN ELAM-1)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ intercellular) (NN adhesion) (NN molecule) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN ICAM-1)) (-RRB- -RRB-))))) (-RRB- -RCB-)))))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB therefore)) (VP (VBD determined) (SBAR (IN whether) (S (NP-SBJ-13 (NNS corticosteroids)) (VP (VBP suppress) (NP (NN inflammation)) (PP (IN by) (S (NP-SBJ (-NONE- *-13)) (VP (VBG inhibiting) (NP (NP (JJ endothelial) (NN expression)) (PP (IN of) (NP (NP (NP (NN adhesion) (NNS molecules)) (PP (IN for) (NP (NNS neutrophils)))) (PRN (-LRB- -LRB-) (NP (JJ polymorphonuclear) (NNS leukocytes)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP-SBJ (NP (NN Preincubation)) (PP (IN of) (NP (JJ endothelial) (NNS cells))) (PP (IN with) (NP (NP (NN endotoxin)) (PRN (-LRB- -LCB-) (FRAG (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (, ,) (NP (CD 1) (NN (ml microgram)))) (-RRB- -RCB-))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT a) (ADJP (JJ 4-fold)) (NN increase)) (PP (IN in) (NP (NP (JJ subsequent) (NN adherence)) (PP (IN of) (NP (NP (JJ polymorphonuclear) (NNS leukocytes)) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (NN P)) (VP (VBG &lt;) (NP (CD 0.0001)))) (, ,) (S (NP-SBJ (NN n)) (VP (JJ =) (NP-PRD (CD 10))))) (-RRB- -RRB-)))) (PP (TO to) (NP (JJ endothelial) (NNS cells)))))) (, ,) (NP (NP (DT an) (NN increase)) (SBAR (WHNP-14 (WDT that)) (S (NP-SBJ-15 (-NONE- *T*-14)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN attenuated) (NP (-NONE- *-15)) (SBAR-TMP (WHADVP-16 (WRB when)) (S (NP-SBJ-17 (JJ endothelial) (NNS cells)) (VP (VBD were) (VP (VBN treated) (NP (-NONE- *-17)) (PP (IN with) (NP (NP (NN dexamethasone)) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (NN IC50)) (VP (VBG &lt;) (NP (CD 1) (NN nM)))) (, ,) (S (NP-SBJ (NN P)) (VP (VBG &lt;) (NP (CD 0.0001)))) (, ,) (S (NP-SBJ (NN n)) (VP (VBG =) (NP-PRD-COOD (NP (CD 6)) (CC or) (NP (CD 7)))))) (-RRB- -RRB-)))) (PP-TMP (IN during) (NP (NP (NN preincubation)) (PP (IN with) (NP (NN LPS))))) (ADVP (-NONE- *T*-16)))))))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-COOD (NP (NP (DT the) (NN steroid) (NN receptor) (NN agonist) (NN cortisol)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 10) (NN microM))) (-RRB- -RRB-))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (PRP$ its) (JJ inactive) (NN metabolite) (NN tetrahydrocortisol)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 10) (NN microM))) (-RRB- -RRB-))) (, ,)) (VP (VBD diminished) (NP (JJ LPS-induced) (JJ endothelial) (NN cell) (NN adhesiveness))) (. .))
(S (NP-SBJ-18 (JJ Further) (NN evidence) (SBAR (IN that) (S (NP-SBJ-19 (NP (DT the) (NN action)) (PP (IN of) (NP (NN dexamethasone)))) (VP (VBD was) (VP (VBN mediated) (NP (-NONE- *-19)) (PP (IN through) (NP (NP (NN ligation)) (PP (IN of) (NP (NP (NN corticosteroid) (NNS receptors)) (PRN (-LRB- -LCB-) (NP (NP (JJ human) (NN glucocorticoid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS hGRs)) (-RRB- -RRB-))) (-RRB- -RCB-))))))))))) (VP (VBD was) (VP (VBN provided) (NP (-NONE- *-18)) (PP (IN by) (NP-LGS (NP (NNS experiments)) (VP (VBG utilizing) (NP (DT the) (NN steroid) (NN antagonist) (NN RU-486))))))) (. .))
(S (NP-SBJ (NP (NN RU-486)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 10) (NN microM))) (-RRB- -RRB-)) (, ,) (SBAR (WHNP-20 (WDT which)) (S (NP-SBJ-21 (-NONE- *T*-20)) (VP (VBZ prevents) (NP (NP (NN translocation)) (PP (IN of) (NP (VBN ligated) (NN hGR))) (PP (TO to) (NP (DT the) (NN nucleus)))) (PP (IN by) (S (NP-SBJ (-NONE- *-21)) (VP (VBG inhibiting) (NP (NP (NN dissociation)) (PP (IN of) (NP (NN hGR))) (PP (IN from) (NP (NN heat) (NN shock) (NN protein) (CD 90)))))))))) (, ,)) (ADVP (RB completely)) (VP (VBD aborted) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN dexamethasone))) (PP (IN on) (NP (NP (NN adhesiveness)) (PP (IN of) (NP (NP (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (NN P)) (VP (VBG &lt;) (NP (CD 0.0005)))) (, ,) (S (NP-SBJ (NN n)) (VP (JJ =) (NP-PRD (CD 3))))) (-RRB- -RRB-)))))))) (. .))
(S (NP-SBJ (NP (NN Treatment)) (PP (IN of) (NP (JJ endothelial) (NNS cells))) (PP (IN with) (NP (NP (NN LPS)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 1) (NN (ml microgram)))) (-RRB- -RRB-))))) (VP-COOD (VP (VBD stimulated) (NP-100 (NP (NN transcription)) (PP (IN of) (NP (NN ELAM-1)))) (, ,) (SBAR-101 (IN as) (S (NP-SBJ-22 (-NONE- *)) (VP (VBN shown) (NP (-NONE- *-22)) (PP (IN by) (NP (NN Northern) (NN blot) (NN analysis))))))) (, ,) (CC and) (VP (NP=100 (NP (NN expression)) (PP (IN of) (NP (JJ membrane-associated) (NP-COOD (NP (NN ELAM-1)) (CC and) (NP (NN ICAM-1)))))) (, ,) (SBAR=101 (IN as) (S (NP-SBJ-23 (-NONE- *)) (VP (VBN shown) (NP (-NONE- *-23)) (PP (IN by) (NP (NP (JJ quantitative) (NN immunofluorescence)) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (DT both) (NN P)) (VP (VBG &lt;) (NP (CD 0.001)))) (, ,) (S (NP-SBJ (NN n)) (VP (VBG =) (NP-PRD (CD 9))))) (-RRB- -RRB-))))))))) (. .))
(S (S (NP-SBJ (NN Dexamethasone)) (ADVP (RB markedly)) (VP (VBD inhibited) (NP-COOD (NP (NP (JJ LPS-stimulated) (NN accumulation)) (PP (IN of) (NP (NP (NN mRNA)) (PP (IN for) (NP (NN ELAM-1)))))) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN ELAM-1)) (CC and) (NP (NN ICAM-1))) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (NN IC50)) (VP (VBG &lt;) (NP (CD 10) (NN nM)))) (, ,) (S (NP-SBJ (DT both) (NN P)) (VP (VBG &lt;) (NP (CD 0.001)))) (, ,) (S (NP-SBJ (NN n)) (VP (VBG =) (NP-PRD (CD 4-9))))) (-RRB- -RRB-))))))) (: ;)) (S (NP-SBJ-24 (NP (NN inhibition)) (PP (IN of) (NP (NN expression))) (PP (IN by) (NP (NN dexamethasone)))) (VP (VBD was) (VP (VBN reversed) (NP (-NONE- *-24)) (PP (IN by) (NP-LGS (NP (NN RU-486)) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (DT both) (NN P)) (VP (VBG &lt;) (NP (CD 0.005)))) (, ,) (S (NP-SBJ (NN n)) (VP (VBG =) (NP-PRD (CD 4-6))))) (-RRB- -RRB-)))))) (. .)))
(S (SBAR-ADV (IN As) (FRAG (PP (IN in) (NP (DT the) (NN adhesion) (NNS studies))))) (, ,) (NP-SBJ-COOD (NP (NN cortisol)) (CONJP (CC but) (RB not)) (NP (NN tetrahydrocortisol))) (VP (VBD inhibited) (NP (NP (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN ELAM-1)) (CC and) (NP (NN ICAM-1))) (PRN (-LRB- -LRB-) (S-COOD (S (NP-SBJ (DT both) (NN P)) (VP (VBG &lt;) (NP (CD 0.005)))) (, ,) (S (NP-SBJ (NN n)) (VP (JJ =) (NP-PRD-COOD (NP (CD 3)) (CC or) (NP (CD 4)))))) (-RRB- -RRB-)))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN sodium) (NN salicylate)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 1) (NN mM))) (-RRB- -RRB-))) (VP (VBD inhibited) (NP (NP-COOD (CC neither) (NP (NN adhesion)) (CC nor) (NP (NN expression))) (PP (IN of) (NP (DT these) (NN adhesion) (NNS molecules))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NP (NN antagonism)) (PP (IN by) (NP (NN dexamethasone))) (PP (IN of) (NP (JJ endotoxin-induced) (NN inflammation)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ specific) (NN instance)) (PP (IN of) (NP (DT the) (JJ general) (JJ biological) (NN principle) (SBAR (IN that) (S (NP-SBJ (DT the) (NN glucocorticoid) (NN receptor)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ hormone-dependent) (NN regulator)) (PP (IN of) (NP (NN transcription)))))))))))))) (. .))
